These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 7518390

  • 1. Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4'-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells.
    Borrel MN, Pereira E, Fiallo M, Garnier-Suillerot A.
    Eur J Biochem; 1994 Jul 01; 223(1):125-33. PubMed ID: 7518390
    [Abstract] [Full Text] [Related]

  • 2. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E, Tarasiuk J, Garnier-Suillerot A.
    Chem Biol Interact; 1998 Jul 03; 114(1-2):61-76. PubMed ID: 9744556
    [Abstract] [Full Text] [Related]

  • 3. Interaction of multidrug-resistant Chinese hamster ovary cells with the peptide ionophore gramicidin D.
    Loe DW, Sharom FJ.
    Biochim Biophys Acta; 1994 Feb 23; 1190(1):72-84. PubMed ID: 7509193
    [Abstract] [Full Text] [Related]

  • 4. Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells.
    Pereira E, Borrel MN, Fiallo M, Garnier-Suillerot A.
    Biochim Biophys Acta; 1994 Jan 11; 1225(2):209-16. PubMed ID: 7904185
    [Abstract] [Full Text] [Related]

  • 5. Analysis of Multidrug Transporter in Living Cells. Inhibition of P-glycoprotein-mediated Efflux of Anthracyclines by Ionophores.
    Borrel MN, Pereira E, Fiallo M, Garnier-Suillerot A.
    Met Based Drugs; 1994 Jan 11; 1(2-3):175-82. PubMed ID: 18476229
    [Abstract] [Full Text] [Related]

  • 6. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
    Cleary I, Doherty G, Moran E, Clynes M.
    Biochem Pharmacol; 1997 May 15; 53(10):1493-502. PubMed ID: 9260877
    [Abstract] [Full Text] [Related]

  • 7. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
    Wu X, Whitfield LR, Stewart BH.
    Pharm Res; 2000 Feb 15; 17(2):209-15. PubMed ID: 10751037
    [Abstract] [Full Text] [Related]

  • 8. The effect of crown ethers, tetraalkylammonium salts, and polyoxyethylene amphiphiles on pirarubicin incorporation in K562 resistant cells.
    Borrel MN, Fiallo M, Veress I, Garnier-Suillerot A.
    Biochem Pharmacol; 1995 Dec 22; 50(12):2069-76. PubMed ID: 8849334
    [Abstract] [Full Text] [Related]

  • 9. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S, Garnier-Suillerot A.
    Eur J Pharmacol; 1998 Feb 19; 343(2-3):313-21. PubMed ID: 9570481
    [Abstract] [Full Text] [Related]

  • 10. Effect of monovalent cation ionophores on lymphocyte cellular metabolism.
    Arslan P, Montecucco C, Celi D, Pozzan T.
    Biochim Biophys Acta; 1981 Apr 22; 643(1):177-81. PubMed ID: 6165389
    [Abstract] [Full Text] [Related]

  • 11. Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.
    Tkaczyk-Gobis K, Tarasiuk J, Seksek O, Stefanska B, Borowski E, Garnier-Suillerot A.
    Eur J Pharmacol; 2001 Feb 16; 413(2-3):131-41. PubMed ID: 11226386
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Probing the interaction of the multidrug-resistance phenotype with the polypeptide ionophore gramicidin D via functional channel formation.
    Assaraf YG, Borgnia MJ.
    Eur J Biochem; 1994 Jun 15; 222(3):813-24. PubMed ID: 7517866
    [Abstract] [Full Text] [Related]

  • 16. Reversal of multidrug resistance by valinomycin is overcome by CCCP.
    Goda K, Krasznai Z, Gaspar R, Lankelma J, Westerhoff HV, Damjanovich S, Szabó G.
    Biochem Biophys Res Commun; 1996 Feb 15; 219(2):306-10. PubMed ID: 8604982
    [Abstract] [Full Text] [Related]

  • 17. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
    Rhodes T, Barrand MA, Twentyman PR.
    Br J Cancer; 1994 Jul 15; 70(1):60-6. PubMed ID: 7912544
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells.
    Frezard F, Garnier-Suillerot A.
    Eur J Biochem; 1991 Mar 14; 196(2):483-91. PubMed ID: 1672520
    [Abstract] [Full Text] [Related]

  • 19. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
    Takeda Y, Nishio K, Sugimoto Y, Kasahara K, Kubo S, Fujiwara Y, Niitani H, Saijo N.
    Int J Cancer; 1991 Jul 30; 48(6):931-7. PubMed ID: 1677641
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
    Naito M, Tsuge H, Kuroko C, Koyama T, Tomida A, Tatsuta T, Heike Y, Tsuruo T.
    J Natl Cancer Inst; 1993 Feb 17; 85(4):311-6. PubMed ID: 7678867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.